Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Other Non-Current Assets for 7 consecutive years, with $35000.0 as the latest value for Q1 2025.
- Quarterly Other Non-Current Assets rose 40.0% to $35000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $35000.0 through Mar 2025, up 40.0% year-over-year, with the annual reading at $25000.0 for FY2024, 0.0% changed from the prior year.
- Other Non-Current Assets hit $35000.0 in Q1 2025 for Benitec Biopharma, down from $56000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $567000.0 in Q3 2023 to a low of $9000.0 in Q1 2021.
- Historically, Other Non-Current Assets has averaged $152687.5 across 5 years, with a median of $30000.0 in 2021.
- Biggest five-year swings in Other Non-Current Assets: soared 5444.44% in 2021 and later plummeted 94.99% in 2022.
- Year by year, Other Non-Current Assets stood at $499000.0 in 2021, then tumbled by 94.99% to $25000.0 in 2022, then skyrocketed by 1644.0% to $436000.0 in 2023, then tumbled by 87.16% to $56000.0 in 2024, then tumbled by 37.5% to $35000.0 in 2025.
- Business Quant data shows Other Non-Current Assets for BNTC at $35000.0 in Q1 2025, $56000.0 in Q3 2024, and $25000.0 in Q2 2024.